195 related articles for article (PubMed ID: 12806538)
1. [Costs of ambulant care for patients with inflammatory bowel disease in general practice].
Beiche A; König HH; Ebinger M; Matysiak-Klose D; Braun V; Leidl R
Z Gastroenterol; 2003 Jun; 41(6):527-36. PubMed ID: 12806538
[TBL] [Abstract][Full Text] [Related]
2. [Cost of general medical care of patients suffering from chronic inflammatory bowel disease].
Bokemeyer B
Z Gastroenterol; 2003 Sep; 41(9):963-4. PubMed ID: 13130334
[No Abstract] [Full Text] [Related]
3. [Cost measurement based on a cost diary in patients with inflammatory bowel disease].
Rösch M; Leidl R; Tirpitz Cv; Reinshagen M; Adler G; König HH
Z Gastroenterol; 2002 Apr; 40(4):217-28. PubMed ID: 11961730
[TBL] [Abstract][Full Text] [Related]
4. Cost analysis and cost determinants in a European inflammatory bowel disease inception cohort with 10 years of follow-up evaluation.
Odes S; Vardi H; Friger M; Wolters F; Russel MG; Riis L; Munkholm P; Politi P; Tsianos E; Clofent J; Vermeire S; Monteiro E; Mouzas I; Fornaciari G; Sijbrandij J; Limonard C; Van Zeijl G; O'morain C; Moum B; Vatn M; Stockbrugger R;
Gastroenterology; 2006 Sep; 131(3):719-28. PubMed ID: 16952541
[TBL] [Abstract][Full Text] [Related]
5. [Cost of early management of chronic inflammatory intestinal disease].
Rolland N; Grandbastien B; Merle V; Gower-Rousseau C; Yzet T; Marti R; Lerebours E; Dupas JL; Czernichow P; Salomez JL; Lebrun T; Cortot A
Gastroenterol Clin Biol; 1999 Apr; 23(4):483-8. PubMed ID: 10416112
[TBL] [Abstract][Full Text] [Related]
6. [Measurement of outpatient treatment costs of chronic inflammatory bowel diseases at a German university hospital].
Rösch M; Leidl R; Thomas S; von Tirpitz C; Reinshagen M; Adler G; König HH
Med Klin (Munich); 2002 Mar; 97(3):128-36. PubMed ID: 11957787
[TBL] [Abstract][Full Text] [Related]
7. Cost of outpatient care in patients with inflammatory bowel disease in a German University Hospital.
Ebinger M; Leidl R; Thomas S; Von Tirpitz C; Reinshagen M; Adler G; Konig HH
J Gastroenterol Hepatol; 2004 Feb; 19(2):192-9. PubMed ID: 14731130
[TBL] [Abstract][Full Text] [Related]
8. [Health economic impact of heart failure: An analysis of the nationwide German database].
Zugck C; Müller A; Helms TM; Wildau HJ; Becks T; Hacker J; Haag S; Goldhagen K; Schwab JO
Dtsch Med Wochenschr; 2010 Apr; 135(13):633-8. PubMed ID: 20333603
[TBL] [Abstract][Full Text] [Related]
9. Health-economic comparison of three recommended drugs for the treatment of osteoporosis.
Brecht JG; Kruse HP; Möhrke W; Oestreich A; Huppertz E
Int J Clin Pharmacol Res; 2004; 24(1):1-10. PubMed ID: 15575171
[TBL] [Abstract][Full Text] [Related]
10. [Juvenile obesity and comorbidity type 2 diabetes mellitus (T2 DM) in Germany: development and cost-of-illness analysis].
Wolfenstetter SB
Gesundheitswesen; 2006 Oct; 68(10):600-12. PubMed ID: 17099820
[TBL] [Abstract][Full Text] [Related]
11. Healthcare costs of inflammatory bowel disease have shifted from hospitalisation and surgery towards anti-TNFα therapy: results from the COIN study.
van der Valk ME; Mangen MJ; Leenders M; Dijkstra G; van Bodegraven AA; Fidder HH; de Jong DJ; Pierik M; van der Woude CJ; Romberg-Camps MJ; Clemens CH; Jansen JM; Mahmmod N; van de Meeberg PC; van der Meulen-de Jong AE; Ponsioen CY; Bolwerk CJ; Vermeijden JR; Siersema PD; van Oijen MG; Oldenburg B;
Gut; 2014 Jan; 63(1):72-9. PubMed ID: 23135759
[TBL] [Abstract][Full Text] [Related]
12. [Cost of care for depressive disorders in primary and specialized care in Germany].
Salize HJ; Stamm K; Schubert M; Bergmann F; Härter M; Berger M; Gaebel W; Schneider F
Psychiatr Prax; 2004 Apr; 31(3):147-56. PubMed ID: 15042478
[TBL] [Abstract][Full Text] [Related]
13. Economic burden of Parkinson's disease in a developing country: a retrospective cost analysis in Shanghai, China.
Wang G; Cheng Q; Zheng R; Tan YY; Sun XK; Zhou HY; Ye XL; Wang Y; Wang Z; Sun BM; Chen SD
Mov Disord; 2006 Sep; 21(9):1439-43. PubMed ID: 16773620
[TBL] [Abstract][Full Text] [Related]
14. Costs and quality of life in multiple sclerosis in The Netherlands.
Kobelt G; Berg J; Lindgren P; Anten B; Ekman M; Jongen PJ; Polman C; Uitdehaag B
Eur J Health Econ; 2006 Sep; 7 Suppl 2():S55-64. PubMed ID: 17310343
[TBL] [Abstract][Full Text] [Related]
15. The incidence of inflammatory bowel disease in a rural region of Southern Germany: a prospective population-based study.
Ott C; Obermeier F; Thieler S; Kemptner D; Bauer A; Schölmerich J; Rogler G; Timmer A
Eur J Gastroenterol Hepatol; 2008 Sep; 20(9):917-23. PubMed ID: 18794607
[TBL] [Abstract][Full Text] [Related]
16. Costs and quality of life for patients with multiple sclerosis in Belgium.
Kobelt G
Eur J Health Econ; 2006 Sep; 7 Suppl 2():S24-33. PubMed ID: 17318662
[TBL] [Abstract][Full Text] [Related]
17. Costs and quality of life of multiple sclerosis in Austria.
Kobelt G; Berg J; Lindgren P; Plesnilla C; Baumhackl U; Berger T; Kolleger H; Vass K
Eur J Health Econ; 2006 Sep; 7 Suppl 2():S14-23. PubMed ID: 17310339
[TBL] [Abstract][Full Text] [Related]
18. [Costs of ambulatory care for RA patients in Germany].
Mittendorf T; Merkesdal S; Zeidler H; Graf von der Schulenburg JM; Ruof J
Med Klin (Munich); 2005 May; 100(5):255-61. PubMed ID: 15902379
[TBL] [Abstract][Full Text] [Related]
19. Suspected inflammatory bowel disease--the clinical and economic impact of competing diagnostic strategies.
Dubinsky MC; Johanson JF; Seidman EG; Ofman JJ
Am J Gastroenterol; 2002 Sep; 97(9):2333-42. PubMed ID: 12358253
[TBL] [Abstract][Full Text] [Related]
20. Costs and quality of life of multiple sclerosis in Germany.
Kobelt G; Berg J; Lindgren P; Elias WG; Flachenecker P; Freidel M; König N; Limmroth V; Straube E
Eur J Health Econ; 2006 Sep; 7 Suppl 2():S34-44. PubMed ID: 17310337
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
